Beta-blocker under-use in COPD patients

BACKGROUND: Cardiovascular (CVS) comorbidities are common in COPD and contribute significantly to morbidity and mortality, especially following acute exacerbations of COPD (AECOPD). Beta-blockers (BBs) are safe and effective in COPD patients, with demonstrated survival benefit following myocardial i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Kuan Pin, Loughrey, Sarah, Musk, Michael, Lavender, Melanie, Wrobel, Jeremy P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655126/
https://www.ncbi.nlm.nih.gov/pubmed/29089752
http://dx.doi.org/10.2147/COPD.S144333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655126/
https://www.ncbi.nlm.nih.gov/pubmed/29089752
http://dx.doi.org/10.2147/COPD.S144333

Ejemplares similares